DHS plans ‘large investments’ in biosurveillance as it ramps up capabilities

Executive Summary

The DHS (Department of Homeland Security) Science and Technology Directorate (S&T), via HSARPA, is planning "large investments" to ramp up biosurveillance capabilities. The stated program elements include expanding testing sites beyond New York City to Austin, Miami, and Seattle; hiring new positions within HSARPA; developing R&D roadmaps; and seeking industry partnerships for AI-assisted biodetection and environmental monitoring technologies. This represents a significant procurement and partnership opportunity for firms with strengths in biosurveillance, biological threat detection, sensors, AI/ML analytics, environmental monitoring, data integration, R&D services, and public health technology.

Contractors should pay attention now because the activity combines near-term operational expansions (new testing sites) with longer-term R&D and procurement signals (roadmaps, industry partnerships, HSARPA hiring). Firms that align technical capabilities, compliance readiness (per the listed compliance surfaces), and contractual access (via the listed vehicles) will be positioned to respond to solicitations, pilots, and partnership calls as they emerge. Monitoring HSARPA and S&T announcements and preparing teaming, demonstrations, and compliance artifacts will improve capture prospects.

Impact Matrix

Biosurveillance

• Risk Level: Critical
• Opportunity: Major program focus; opportunities in system development, deployment, and sustainment tied to expanded testing sites and HSARPA R&D/partnership solicitations. Specific opportunities include work under NAICS codes: 541714, 541715, 541380, 541512, 541330, 334516, 334517, 541690, 541620. Potential contract vehicles called out in Tags: OASIS+, 8(a) STARS III, Alliant 3, GSA (General Services Administration) MAS, DHS EAGLE II. Agencies: DHS, S&T, HSARPA.
• Timeline: Timeline TBD pending source review.
• Action Required: Prepare capability statements and demos focused on biosurveillance deployments; map existing products to testing-site scenarios (Austin, Miami, Seattle); assemble teaming partners that cover lab-to-cloud data flows; ensure compliance artifacts for listed regimes are current.
• Competitive Edge: Offer integrated pilot proposals that couple sensor/sampling hardware with analytics and data integration and demonstrate rapid, fielded testing at candidate city sites.

Homeland Security

• Risk Level: High
• Opportunity: Portfolio-level funding and program growth within DHS S&T/HSARPA that touches operational homeland security biosurveillance missions. Contractors can position for programmatic support, integration, and sustainment work with DHS.
• Timeline: Timeline TBD pending source review.
• Action Required: Align business development with DHS acquisition channels; highlight prior relevant homeland security experience and compliance readiness; cultivate primes/subs relationships for listed vehicles.
• Competitive Edge: Present cross-domain solutions showing how biosurveillance data can integrate into broader DHS situational awareness and response workflows.

AI/ML Analytics

• Risk Level: High
• Opportunity: Industry partnerships sought for AI-assisted biodetection and analytics; work spans algorithm R&D, model validation, operationalization, and integration into monitoring systems. NAICS and vehicles listed in Tags apply.
• Timeline: Timeline TBD pending source review.
• Action Required: Prepare data-ready model baselines and validation plans; document datasets, ethical/privacy controls, and FedRAMP (Federal Risk and Authorization Management Program)/FISMA/Federal compliance posture as relevant; identify pilot partners for on-the-ground validation.
• Competitive Edge: Propose explainable AI pipelines tailored to biodetection use cases and include operational performance metrics and deployment blueprints for urban test sites.

Sensor Technologies

• Risk Level: High
• Opportunity: Demand for environmental and biodetection sensors and integration into monitoring networks tied to testing-site expansion and environmental monitoring goals. NAICS and vehicles from Tags apply.
• Timeline: Timeline TBD pending source review.
• Action Required: Validate sensor performance for planned deployment environments; prepare rapid-prototype and test plans for city-scale pilot sites; ensure manufacturability and sustainment planning.
• Competitive Edge: Bundle sensor platforms with edge processing and secure data handoff to analytics to reduce integration friction for government customers.

Biological Threat Detection

• Risk Level: Critical
• Opportunity: Core focus area for HSARPA/S&T investments; opportunities across detection modalities, assay integration, field testing, and system-of-systems approaches. NAICS and vehicles from Tags apply.
• Timeline: Timeline TBD pending source review.
• Action Required: Prepare evidence packages (performance, sensitivity/specificity) and rapid deployment scenarios; check alignment with listed compliance surfaces and SAFETY Act considerations.
• Competitive Edge: Demonstrate end-to-end detection-to-decision chains with real-world test data and operational use-case narratives for Austin, Miami, and Seattle pilots.

Environmental Monitoring

• Risk Level: High
• Opportunity: Expansion of environmental monitoring tied to biosurveillance, including sensor networks and data collection systems for monitoring urban environments at new testing locations.
• Timeline: Timeline TBD pending source review.
• Action Required: Develop integrated environmental sensing proposals; include data fusion and quality assurance plans; plan for cross-jurisdictional deployment coordination.
• Competitive Edge: Leverage scalable network designs and low-maintenance sensor strategies that minimize operational costs for municipal or regional pilot deployments.

Data Integration

• Risk Level: High
• Opportunity: Systems and services to integrate sensor outputs, laboratory results, and analytics into dashboards and decision support for DHS/S&T/HSARPA programs. NAICS and vehicles from Tags apply.
• Timeline: Timeline TBD pending source review.
• Action Required: Prepare reference architectures, interoperability approaches, and security/compliance documentation (NIST 800-171 (NIST Special Publication 800-171), FedRAMP, FISMA as relevant).
• Competitive Edge: Offer modular, standards-based integration layers with secure APIs and role-based access controls to accelerate government adoption.

R&D Services

• Risk Level: High
• Opportunity: HSARPA hiring and roadmap development imply R&D contracting and funded R&D partnerships. Firms providing mid-to-long-range R&D planning, prototyping, and transition support are in scope. NAICS and vehicles from Tags apply.
• Timeline: Timeline TBD pending source review.
• Action Required: Prepare white papers, roadmaps, and proposal-ready technical approaches aligned to HSARPA S&T research priorities; identify potential teaming arrangements with academic and public health partners.
• Competitive Edge: Present end-to-end transition-to-operations plans tying R&D outputs to demonstrable deployment at the cited city sites.

Public Health Technology

• Risk Level: High
• Opportunity: Overlap between biosurveillance investments and public health technology modernization—opportunities for informatics, reporting, and decision-support tools that serve public health stakeholders.
• Timeline: Timeline TBD pending source review.
• Action Required: Map product capabilities to public health workflows; prepare data sharing and privacy compliance approaches; pursue partnerships that bridge clinical/public-health and DHS operational needs.
• Competitive Edge: Show interoperability with public health data standards and offer piloting strategies in the named cities to prove operational value.

Cross-Segment Implications

• Sensor Technologies -> Data Integration -> AI/ML Analytics: sensor outputs will drive analytics; effective deployment requires tight integration across these segments to deliver usable biosurveillance insights.
• Biosurveillance / Biological Threat Detection -> Public Health Technology: detection results must feed public health workflows; vendors able to bridge operational DHS requirements and public health systems gain advantage.
• R&D Services -> Operational Deployments: HSARPA R&D roadmaps and hiring indicate an emphasis on transitioning research into pilots and field tests (e.g., Austin, Miami, Seattle), so R&D contractors should plan for transition and sustainment activities.
• Compliance Surface: Cross-cutting need to address NIST 800-171, FedRAMP, FISMA and SAFETY Act considerations will affect solution architecture, timelines, and subcontracting decisions.
• Contracting Channels: The listed contract vehicles and NAICS codes in Tags imply multiple procurement paths; contractors should coordinate capture strategies across vehicles and segments rather than treating each as isolated opportunities.